Use of an anti-Ang2 antibody
US9505841B2 · kind B2 · utility
5Cited by
7References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 29, 2014 |
| Grant date | Nov 29, 2016 |
| Priority date | — |
| Expiry date | Oct 9, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing or treating cancer using an anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes to a Tie2 receptor while bound with Ang2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.